Bridging the Gap Between Participants and Clinical Trials

An Open-Label Biomarker Study of BHV-1300 in Graves’ Disease

CONDITION

Metabolic and Endocrine

GENDER

Both males and females

AGE GROUP

From 18

to 65 years

STATUS

Recruiting

The purpose of this study is to determine if BHV-1300 is a safe treatment in participants with Graves’ Disease and to explore its effect on disease-specific biomarkers.

CONTACT DETAILS

Clinical Trial Site: Clinical Trials Institute
Phone Number: (03) 4252 7023 Email: Info@clinicaltrialsinstitute.com.au Location: 101/1 Cylinders Drive, Torquay VIC, Australia

Studies Contact Form

Name*
First Last
Email*
Phone Number
Message*
CAPTCHA
- Send me updates about clinical trials
This field is hidden when viewing the form
All
- All

Approved By: Bellberry

Clinical Trial Registry Link: Click Here